Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- befree-2016 importedOn "2016-02-19" NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_assertion wasGeneratedBy ECO_0000203 NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_assertion wasDerivedFrom befree-2016 NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_assertion SIO_000772 11522269 NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_assertion evidence source_evidence_literature NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.
- NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_assertion description "[New or potentially new markers for breast cancer include BRCA1 and BRCA2 for selecting patients at high risk of developing breast cancer, urokinase plasminogen activator and PA1-1 for assessing prognosis and HER-2 for predicting response to the therapeutic antibody, Herceptin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328170.RAPML2fe4SP5fbOw5VO3qqdL5Uv3aWxHWZ_1iYsPSJisM130_provenance.